Literature DB >> 19957617

[A prospective study on the association between dyslipidemia and hypertension].

Zhi-Rong Guo1, Xiao-Shu Hu, Ming Wu, Ming-Hao Zhou, Zheng-Yuan Zhou.   

Abstract

OBJECTIVE: To discuss the risks of hypertension development with relation to the level of lipid variables among populations who had normal blood pressure at baseline study.
METHODS: In April 2000, under the support of project "prevention of metabolic syndrome and multi-metabolic disorders in Jiangsu province", a cohort study was performed to obtain the baseline data among 8685 persons from age 34 to 74. In June of 2006, a follow-up investigation was carried out among those who had been in the study for 5 years after the baseline study started. 2603 persons who met the selection criteria and showed normal blood pressure during baseline study, were recruited in this investigation. The interval from the baseline to the follow-up studies was 6.38 years on average. Relationship between the risk of developing hypertension and the baseline level of lipid variables were analyzed.
RESULTS: Relations between baseline lipid levels and the incidence of hypertension during the follow-up was discovered. In gender and age adjusted model, the lipid variables were all associated with hypertension (trend test, P<0.01). In multivariable-adjusted model, HDL-C [aRR=0.71 (95%CI: 0.61-0.99)], non-HDL-C [aRR=1.28 (95%CI: 1.14-1.83)], TC/HDL-C ratio [aRR=1.41 (95%CI: 1.25-2.03)] and TG [aRR=1.49 (95%CI: 1.30-2.13)] were again associated with hypertension (trend test, P<0.05). Even the aRR was much weakened after the baseline SBP, DBP were adjusted with Cox model, the significant relation of hypertension to HDL-C, TC/HDL-C ratio and TG still existed. Excluding the two factors of obesity (BMI> or =28) and diabetes which had been recognized in marked linking with hypertension, lipid variables were still associated with hypertension.
CONCLUSION: Dyslipidemia might occur before being hypertensive. Hypertension was associated with HDL-C, TC/HDL-C and TG or even exclusion of obesity, diabetes and factors of smoking and drinking or baseline level of SBP, DBP were adjusted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19957617

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  6 in total

1.  Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population.

Authors:  Toshiaki Otsuka; Hirotaka Takada; Yasuhiro Nishiyama; Eitaro Kodani; Yoshiyuki Saiki; Katsuhito Kato; Tomoyuki Kawada
Journal:  J Am Heart Assoc       Date:  2016-03-25       Impact factor: 5.501

2.  Case-control study on peroxisome proliferator-activated receptor gamma polymorphism and interaction with HDL on essential hypertension in Chinese Han.

Authors:  Gang Wang; Ping Xu; Wei Feng; Xianyan Jiang; Tao Zhang; Jian Li
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

3.  Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.

Authors:  Xiaowei Yan; Yong Li; Yugang Dong; Yanhua Wu; Jihu Li; Rui Bian; Dayi Hu
Journal:  Lipids Health Dis       Date:  2019-01-29       Impact factor: 3.876

4.  Polymorphisms of adiponectin gene and gene-lipid interaction with hypertension risk in Chinese coal miners: A matched case-control study.

Authors:  Xiaoqin Hu; Yanfeng Xi; Wenqi Bai; Zhenjun Zhang; Jiahao Qi; Liang Dong; Huiting Liang; Zeyu Sun; Lijian Lei; Guoquan Fan; Chenming Sun; Cheng Huo; Jianjun Huang; Tong Wang
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

5.  Prevalence of hypertension in Chinese cities: a meta-analysis of published studies.

Authors:  Yu-Quan Ma; Wen-Hua Mei; Ping Yin; Xiao-Hui Yang; Sana Kiani Rastegar; Jian-Dong Yan
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

6.  The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China.

Authors:  Chen Chen; Yan Xu; Zhi-rong Guo; Jie Yang; Ming Wu; Xiao-shu Hu
Journal:  Lipids Health Dis       Date:  2014-07-08       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.